Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens

BACKGROUND: In vivo targeting of human papillomavirus (HPV) derived antigens to dendritic cells might constitute an efficient immunotherapeutic strategy against cervical cancer. In previous works, we have shown that the extra domain A from murine fibronectin (mEDA) can be used to target antigens to...

Descripción completa

Detalles Bibliográficos
Autores principales: Arribillaga, Laura, Echeverria, Iciar, Belsue, Viriginia, Gomez, Timothy, Lozano, Teresa, Casares, Noelia, Villanueva, Lorea, Domingos-Pereira, Sonia, Romero, Pedro J, Nardelli-Haefliger, Denise, Hervás-Stubbs, Sandra, Sarobe, Pablo, Rodriguez, María Josefa, Carrascosa, José L, Zürcher, Thomas, Lasarte, Juan José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319778/
https://www.ncbi.nlm.nih.gov/pubmed/32581060
http://dx.doi.org/10.1136/jitc-2020-000704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319778/
https://www.ncbi.nlm.nih.gov/pubmed/32581060
http://dx.doi.org/10.1136/jitc-2020-000704

Ejemplares similares